My Cart

Neuropilin-2

Neuropilin-2 Overview

English NameNeuropilin 2Approved Drugs0
Drugs in Clinical Trials1Target SynonymNeuropilin-2,Vascular endothelial cell growth factor 165 receptor 2,NPN2,NP2,Neuropilin-2a(22),Neuropilin-2b(0),VEGF165R2,PRO2714,Neuropilin-2a(17),Receptor For VEGF165 And Semaphorins Class3
Highest Development StagePhase 3 Clinical
English NameNeuropilin 2
Target SynonymNeuropilin-2,Vascular endothelial cell growth factor 165 receptor 2,NPN2,NP2,Neuropilin-2a(22),Neuropilin-2b(0),VEGF165R2,PRO2714,Neuropilin-2a(17),Receptor For VEGF165 And Semaphorins Class3
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 3 Clinical

Neuropilin-2 Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (1)Biotin-labeled (1)

Neuropilin-2 Background

Neuropilin-1 (Npn-1, previously known as neuropilin) and Neuropilin-2 (previously known as Npn-1-related molecule) are type I transmembrane proteins that bind distinct members of the class III secreted semaphorin subfamily that are implicated in repulsive axon guidance. Neuropilin extracellular domains contain two CUB (complement-binding) domains, two domains with homology to coagulation factors V and VIII, and a MAM (meprin) domain. In the absence of ligands, neuropilins can form homo- and hetero-oligomers via their MAM domains. Expression in developing neurons of the central and peripheral nervous systems is somewhat overlapping but distinct. Npn-1 and Npn-2 are also receptors for VEGF165 on endothelial and tumor cells.

Neuropilin-2 Synonyms

Neuropilin-2,NRP2,VEGF165R2,Neuropilin2,Vascular endothelial cell growth factor 165 receptor 2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
EfzofitimodATYR-1923; KRP-R120Phase 3 ClinicalAtyr PharmaCoronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Sarcoidosis, Pulmonary
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland